AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca reported (IFRS) basic EPS ($ per share) ($)
Form 6-K / 20-F Consolidated Income Statement
Latest, FY2025
6.60
Period ended Dec 31, 2025
Change on a year earlier
+45.4%
4.54 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Reported (IFRS) basic EPS ($ per share) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.60 | +45.4% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 4.54 | +18.2% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 3.84 | +81.1% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 2.12 | +2,550.0% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 0.08 | -96.7% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 2.44 | +136.9% | Form 6-K FY2020Q4 Earnings Release ↗ |
| FY2019 | Dec 31, 2019 | 1.03 | -39.4% | Form 20-F (filed 2020-03-03) ↗ |
| FY2018 | Dec 31, 2018 | 1.70 | -28.3% | Form 20-F (filed 2019-03-05) ↗ |
| FY2017 | Dec 31, 2017 | 2.37 | -14.4% | Form 20-F (filed 2018-03-06) ↗ |
| FY2016 | Dec 31, 2016 | 2.77 | +24.2% | Form 20-F (filed 2018-03-06) ↗ |
| FY2015 | Dec 31, 2015 | 2.23 | – | Form 20-F (filed 2018-03-06) ↗ |
Cite this data
StockData. (2026). AstraZeneca Reported (IFRS) basic EPS ($ per share) ($), annual FY2015–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rep_eps_cmp
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.